Mechanism of MHC Association with Type 1 Diabetes

MHC与1型糖尿病的关联机制

基本信息

  • 批准号:
    7479078
  • 负责人:
  • 金额:
    $ 19.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Susceptibility to and severity of many autoimmune diseases, including type 1 diabetes (T1D), are known to be closely linked with particular class II MHC alleles, but the mechanism of these associations remains unknown. We have found that class II alleles that form unusually low-stability complexes with class II- associated invariant chain peptides (CLIP) are disproportionately represented among alleles that confer susceptibility to autoimmunity. Our recent work indicates that variations in class II/CLIP affinity affect the stability, longevity, and abundance of class II molecules in model antigen presenting cells (APC) and can modulate antigen presentation. Mechanisms by which variations in class II/CLIP affinity could influence susceptibility to autoimmunity thus include alterations in central selection events or peripheral tolerance or activation events, all of which are controlled by antigen presentation. Here, we propose to study whether varying class II/CLIP affinity can influence autoimmune disease pathogenesis in a whole animal. We will: 1) Establish a short-term mouse model of T1D in which the affinity of CLIP for class II has been modulated; this will be achieved by reconstituting irradiated, pre-disease NOD mice with HSC expressing invariant chains with wild type CLIP (with low affinity for MHC II) or mutated CLIP (with high affinity for MHC II); 2) Measure the effects of class II/CLIP affinity on class II stability, longevity, and abundance in primary APC types from these mice, including in the context of inflammatory stimuli; 3) Determine whether modulation of class II/CLIP affinity in BM-derived APC modulates disease and key immunologic features in this model. The results of these experiments will shape future studies, in which we will extend this work in a long-term model to investigate diabetes pathogenesis using mice that stably express high-affinity CLIP/Ii. If expression of high affinity CLIP in hematopoietic cells is sufficient for disease protection, it will provide new therapeutic options for individuals at risk for T1D. Although it has been known for a number of years that certain proteins, the HLA proteins, are a critical genetic risk factor for type 1 diabetes and other debilitating autoimmune diseases, the explanation for this genetic link has remained unknown. We will perform experiments in a mouse model of diabetes to test a novel hypothesis for the mechanism of this association. If successful, our experiments will shed new light on the mechanism(s) of disease initiation and pathogenesis in diabetes, and may suggest new treatment approaches for people who are at high risk for diabetes.
描述(由申请人提供):许多自身免疫性疾病的易感性和严重性,包括1型糖尿病(T1D),已知与特定的II类MHC等位基因密切相关,但这些关联的机制仍不清楚。我们发现,在自身免疫易感性的等位基因中,与第II类相关不变链肽(CLIP)形成异常低稳定性复合体的第II类等位基因的比例不成比例。我们最近的工作表明,II类/CLIP亲和力的变化会影响模型抗原提呈细胞(APC)中II类分子的稳定性、寿命和丰度,并可以调节抗原提呈。因此,II类/CLIP亲和力的变化可能影响自身免疫易感性的机制包括中央选择事件或外周耐受或激活事件的变化,所有这些变化都由抗原提呈控制。 在这里,我们建议研究不同的II类/CLIP亲和力是否会影响整个动物的自身免疫性疾病的发病机制。我们将:1)建立一个短期的T1D小鼠模型,其中CLIP对II类的亲和力已经被调节;这将通过重组受照射的疾病前NOD小鼠的HSC表达不变链来实现,野生型CLIP(对MHC II的亲和力低)或突变的CLIP(对MHC II具有高亲和力);2)测量II类/CLIP亲和力对这些小鼠原始APC类型II类的稳定性、寿命和丰度的影响,包括在炎症刺激的情况下;3)确定BM来源的APC中II类/CLIP亲和力的调节是否调节了疾病和该模型中的关键免疫学特征。这些实验的结果将塑造未来的研究,在这些研究中,我们将在长期模型中扩展这项工作,使用稳定表达高亲和力CLIP/II的小鼠来研究糖尿病的发病机制。如果高亲和力CLIP在造血细胞中的表达足以保护疾病,将为T1D高危个体提供新的治疗选择。尽管多年来人们已经知道,某些蛋白质,即人类白细胞抗原蛋白,是1型糖尿病和其他衰弱的自身免疫性疾病的关键遗传风险因素,但这种遗传联系的解释仍然不清楚。我们将在糖尿病小鼠模型上进行实验,以测试这种关联机制的新假说。如果成功,我们的实验将为糖尿病的疾病起始和发病机制(S)提供新的线索,并可能为糖尿病高危人群提供新的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elizabeth D Mellins其他文献

Systemic juvenile idiopathic arthritis is associated with HLA-DRB1 in Europeans and Americans of European descent
  • DOI:
    10.1186/1546-0096-10-s1-a6
  • 发表时间:
    2012-07-13
  • 期刊:
  • 影响因子:
    2.300
  • 作者:
    Michael Ombrello;Elaine F Remmers;Alexei A Grom;Wendy Thomson;Alberto Martini;Marco Gattorno;Seza Ozen;Ahmet Gul;John F Bohnsack;Andrew S Zeft;Elizabeth D Mellins;Jane L Park;Claudio Len;Colleen Satorius;Ricardo AG Russo;Terri H Finkel;Rae SM Yeung;Rayfel Schneider;Sampath Prahalad;David N Glass;Roger C Allen;Nico Wulffraat;Pierre Quartier;Maria Odete E Hilario;Kevin Murray;Sheila Oliveira;Jordi Anton;Anne Hinks;Eleftheria Zeggini;Carl Langefeld;Susan Thompson;Jeffrey Chaitow;Justine Ellis;Davinder Singh;Andre Cavalvanti;Blanca Bica;Flavio Sztajnbok;Hakon Hakonarson;Katherine A Siminovitch;Kirsten Minden;Peter Haas;Tobias Schwarz;Daniel L Kastner;Patricia Woo
  • 通讯作者:
    Patricia Woo
Demographic, clinical and treatment characteristics of the carra registry systemic JIA cohort
  • DOI:
    10.1186/1546-0096-12-s1-p64
  • 发表时间:
    2014-09-17
  • 期刊:
  • 影响因子:
    2.300
  • 作者:
    Ginger Janow;Laura Schanberg;Soko Setoguchi;Elizabeth D Mellins;Rayfel Schneider;Yukiko Kimura
  • 通讯作者:
    Yukiko Kimura

Elizabeth D Mellins的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elizabeth D Mellins', 18)}}的其他基金

Inflammasome function and SJIA
炎症小体功能和 SJIA
  • 批准号:
    8513260
  • 财政年份:
    2012
  • 资助金额:
    $ 19.75万
  • 项目类别:
Inflammasome function and SJIA
炎症小体功能和 SJIA
  • 批准号:
    8285388
  • 财政年份:
    2012
  • 资助金额:
    $ 19.75万
  • 项目类别:
Immunoglobulin as a novel ligand for HLA-DM
免疫球蛋白作为 HLA-DM 的新型配体
  • 批准号:
    8177239
  • 财政年份:
    2011
  • 资助金额:
    $ 19.75万
  • 项目类别:
Immunoglobulin as a novel ligand for HLA-DM
免疫球蛋白作为 HLA-DM 的新型配体
  • 批准号:
    8264930
  • 财政年份:
    2011
  • 资助金额:
    $ 19.75万
  • 项目类别:
MHC association in autoimmune arthritis
MHC 与自身免疫性关节炎的关系
  • 批准号:
    8093106
  • 财政年份:
    2010
  • 资助金额:
    $ 19.75万
  • 项目类别:
A role for IL-1 in SJIA monocyte phenotypes: A RAPPORT ancillary study
IL-1 在 SJIA 单核细胞表型中的作用:一项 RAPPORT 辅助研究
  • 批准号:
    8325175
  • 财政年份:
    2010
  • 资助金额:
    $ 19.75万
  • 项目类别:
A role for IL-1 in SJIA monocyte phenotypes: A RAPPORT ancillary study
IL-1 在 SJIA 单核细胞表型中的作用:一项 RAPPORT 辅助研究
  • 批准号:
    8146977
  • 财政年份:
    2010
  • 资助金额:
    $ 19.75万
  • 项目类别:
A role for IL-1 in SJIA monocyte phenotypes: A RAPPORT ancillary study
IL-1 在 SJIA 单核细胞表型中的作用:一项 RAPPORT 辅助研究
  • 批准号:
    8530018
  • 财政年份:
    2010
  • 资助金额:
    $ 19.75万
  • 项目类别:
A role for IL-1 in SJIA monocyte phenotypes: A RAPPORT ancillary study
IL-1 在 SJIA 单核细胞表型中的作用:一项 RAPPORT 辅助研究
  • 批准号:
    8088935
  • 财政年份:
    2010
  • 资助金额:
    $ 19.75万
  • 项目类别:
Protective Mechanisms Against Pandemic Respiratory Virus (Resource D)
针对流行性呼吸道病毒的保护机制(资源 D)
  • 批准号:
    7657181
  • 财政年份:
    2008
  • 资助金额:
    $ 19.75万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了